Found 52 matching trials
Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma PHASE2 The purpose of this study is to evaluate the efficacy and toxicity of tande...
Show More Location
Multiple Locations
Learn More & Join Trial
Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours N/A The purpose of this study is to determine if the measurement (with a standa...
Show More Location
Ochsner Medical Center - Kenner
Learn More & Join Trial
Study of MIBG-I131 in Patients With Well Differentiated Neuroendocrine Tumors PHASE2 This is a single-arm, unicentric, single-stage, phase 2 clinical study of t...
Show More Location
AC Camargo Cancer Center
Learn More & Join Trial
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma PHASE2 This clinical trial is designed to evaluate the effectiveness and collect a...
Show More Location
University of California-San Francisco
Learn More & Join Trial
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma N/A This is an expanded access protocol/compassionate use single institution st...
Show More Location
Cohen Children's Medical Center
Learn More & Join Trial
131MIBG to Treat Malignant Pheochromocytoma PHASE2 This study will evaluate the effectiveness of 131MIBG in treating malignant...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
MCT for the Harvard/UCSF ROBIN Center NA The goal of the Molecular Characterization Trial (MCT) is to obtain biologi...
Show More Location
University of California, San Francisco
Learn More & Join Trial
N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation PHASE1 RATIONALE: Giving iodine I 131 metaiodobenzylguanidine (\^131I-MIBG) may ki...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma N/A Currently there is no known effective treatment for patients with advanced ...
Show More Status
No Longer Available
Location
Cincinnati Children's Hospital Medical Center
Learn More & Join Trial
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors PHASE2 This is an ongoing prospective Phase II clinical trial evaluating the effic...
Show More Learn More & Join Trial